{"id":"W4255166385","doi":"10.1093/rheumatology/key075.396","title":"172 Secukinumab 150 mg provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: three-year results from Phase 3 trial, MEASURE 2","year":2018,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Ankylosing spondylitis; Secukinumab; Spondylitis; Measure (data warehouse); Physical therapy; Internal medicine; Arthritis; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001048358,0.0005661597,0.001022594,0.0001805255,0.000217213,0.0006847539,0.0003905486,0.000577753,0.004386204],"category_scores_gemma":[0.000518777,0.0002140336,0.000949621,0.0001722942,0.0003916363,0.0004221196,0.000198209,0.00112442,0.0008787631],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000366519,"about_ca_system_score_gemma":0.0004113857,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002928115,"about_ca_topic_score_gemma":0.0008845578,"domain_scores_codex":[0.9996967,0.0001483091,0.00002177178,0.00003935486,0.00004611522,0.00004772013],"domain_scores_gemma":[0.9997137,0.00005035954,0.00009117734,0.00002524446,0.00002638766,0.00009320052],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7407289,0.01762418,0.008670487,0.002102656,0.002534708,0.0002788785,0.0002394451,0.001015763,0.06172256,0.0003473042,0.008391093,0.1563439],"study_design_scores_gemma":[0.6195707,0.3331381,0.0337123,0.0001238497,0.0008762588,0.0004835435,0.00006147385,0.0008687819,0.006629179,0.0001371609,0.004355646,0.00004296865],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910172,0.005663588,0.0002648667,0.000330993,0.0001285774,0.0004753091,0.0006777453,0.0001041791,0.001337601],"genre_scores_gemma":[0.9940812,0.001463545,0.0004611866,0.0005076637,0.0001233581,0.0005147955,0.001128967,0.00002116303,0.001698054],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004386204,"threshold_uncertainty_score":0.01467335,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01948887572875234,"score_gpt":0.2698500501317686,"score_spread":0.2503611744030163,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}